LIGAND PHARMACEUTICALS INCORPORATED Revenue Recognition, Milestone Method, Revenue Recognized
LIGAND PHARMACEUTICALS INCORPORATED (LGNYZ) reported Revenue Recognition, Milestone Method, Revenue Recognized of $1.60 million for the 3-month period ending 2018-03-31, per its 10-Q filed 2018-05-09.
Discontinued › Notes › Revenue Recognition and Deferred Revenue
us-gaap:RevenueRecognitionMilestoneMethodRevenueRecognized · last filed 2018-05-09
- LIGAND PHARMACEUTICALS INCORPORATED revenue recognition, milestone method, revenue recognized for the quarter ending 2018-03-31 was $1.60M.
| Period end | Revenue Recognition, Milestone Method, Revenue Recognized 3 month |
|---|---|
| 2018-03-31 | $1.60M 10-Q · filed 2018-05-09 |